Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Zynerba Pharmaceuticals (NASDAQ:ZYNE)

Share Price
$ 13.03
-0.6 (-4.40 %)
Market Cap
$274.61 m
Proactive Investors - Run By Investors For Investors

Zynerba Pharmaceuticals

At Zynerba Pharmaceuticals, our team is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. Often, these diseases have few, if any, treatment options and can leave patients and their families feeling helpless and alone. Zynerba is committed to developing breakthrough therapies to...

52-week High/Low: $16.46 / $2.82
Sector: Pharma & Biotech
Market Cap: $274.61 m
Website: zynerba.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Zynerba Pharmaceuticals

Zynerba Pharmaceuticals Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use